nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—CYP3A4—bone cancer	0.439	1	CbGaD
Atazanavir—ABCC1—Epirubicin—bone cancer	0.127	0.285	CbGbCtD
Atazanavir—SLCO1B3—Methotrexate—bone cancer	0.0946	0.212	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—bone cancer	0.0675	0.151	CbGbCtD
Atazanavir—ABCC1—Methotrexate—bone cancer	0.0654	0.147	CbGbCtD
Atazanavir—CYP2C9—Cisplatin—bone cancer	0.0251	0.0562	CbGbCtD
Atazanavir—ABCB1—Cisplatin—bone cancer	0.0243	0.0545	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—bone cancer	0.0163	0.0365	CbGbCtD
Atazanavir—ABCB1—Methotrexate—bone cancer	0.0158	0.0354	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—bone cancer	0.00976	0.0219	CbGbCtD
Atazanavir—Lopinavir—CYP3A4—bone cancer	0.0011	0.403	CrCbGaD
Atazanavir—Ritonavir—CYP3A4—bone cancer	0.000924	0.339	CrCbGaD
Atazanavir—Saquinavir—CYP3A4—bone cancer	0.000701	0.257	CrCbGaD
Atazanavir—Decreased appetite—Cisplatin—bone cancer	0.000191	0.0017	CcSEcCtD
Atazanavir—Nasopharyngitis—Doxorubicin—bone cancer	0.00019	0.00169	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Cisplatin—bone cancer	0.00019	0.00169	CcSEcCtD
Atazanavir—Depression—Methotrexate—bone cancer	0.000189	0.00168	CcSEcCtD
Atazanavir—Gastritis—Doxorubicin—bone cancer	0.000188	0.00168	CcSEcCtD
Atazanavir—Pain—Cisplatin—bone cancer	0.000188	0.00167	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000188	0.00167	CcSEcCtD
Atazanavir—Muscular weakness—Doxorubicin—bone cancer	0.000187	0.00167	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000187	0.00167	CcSEcCtD
Atazanavir—Renal failure—Methotrexate—bone cancer	0.000186	0.00166	CcSEcCtD
Atazanavir—Neutropenia—Epirubicin—bone cancer	0.000186	0.00165	CcSEcCtD
Atazanavir—Abdominal distension—Doxorubicin—bone cancer	0.000185	0.00165	CcSEcCtD
Atazanavir—Stomatitis—Methotrexate—bone cancer	0.000184	0.00164	CcSEcCtD
Atazanavir—Pollakiuria—Epirubicin—bone cancer	0.000183	0.00163	CcSEcCtD
Atazanavir—Eosinophilia—Doxorubicin—bone cancer	0.000182	0.00162	CcSEcCtD
Atazanavir—Sweating—Methotrexate—bone cancer	0.000181	0.00162	CcSEcCtD
Atazanavir—Photosensitivity reaction—Epirubicin—bone cancer	0.000181	0.00161	CcSEcCtD
Atazanavir—Feeling abnormal—Cisplatin—bone cancer	0.000181	0.00161	CcSEcCtD
Atazanavir—Weight increased—Epirubicin—bone cancer	0.000181	0.00161	CcSEcCtD
Atazanavir—Haematuria—Methotrexate—bone cancer	0.00018	0.00161	CcSEcCtD
Atazanavir—Pancreatitis—Doxorubicin—bone cancer	0.00018	0.0016	CcSEcCtD
Atazanavir—Weight decreased—Epirubicin—bone cancer	0.00018	0.0016	CcSEcCtD
Atazanavir—Hyperglycaemia—Epirubicin—bone cancer	0.000179	0.00159	CcSEcCtD
Atazanavir—Hepatobiliary disease—Methotrexate—bone cancer	0.000179	0.00159	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000176	0.00156	CcSEcCtD
Atazanavir—Renal failure—Epirubicin—bone cancer	0.000174	0.00155	CcSEcCtD
Atazanavir—Body temperature increased—Cisplatin—bone cancer	0.000174	0.00155	CcSEcCtD
Atazanavir—Neuropathy peripheral—Epirubicin—bone cancer	0.000174	0.00155	CcSEcCtD
Atazanavir—Jaundice—Epirubicin—bone cancer	0.000173	0.00154	CcSEcCtD
Atazanavir—Stomatitis—Epirubicin—bone cancer	0.000173	0.00154	CcSEcCtD
Atazanavir—Urinary tract infection—Epirubicin—bone cancer	0.000172	0.00153	CcSEcCtD
Atazanavir—Neutropenia—Doxorubicin—bone cancer	0.000172	0.00153	CcSEcCtD
Atazanavir—Hepatitis—Methotrexate—bone cancer	0.00017	0.00151	CcSEcCtD
Atazanavir—Sweating—Epirubicin—bone cancer	0.00017	0.00151	CcSEcCtD
Atazanavir—Pollakiuria—Doxorubicin—bone cancer	0.00017	0.00151	CcSEcCtD
Atazanavir—Haematuria—Epirubicin—bone cancer	0.000169	0.0015	CcSEcCtD
Atazanavir—Urinary tract disorder—Methotrexate—bone cancer	0.000168	0.00149	CcSEcCtD
Atazanavir—Photosensitivity reaction—Doxorubicin—bone cancer	0.000168	0.00149	CcSEcCtD
Atazanavir—Hepatobiliary disease—Epirubicin—bone cancer	0.000167	0.00149	CcSEcCtD
Atazanavir—Weight increased—Doxorubicin—bone cancer	0.000167	0.00149	CcSEcCtD
Atazanavir—Urethral disorder—Methotrexate—bone cancer	0.000166	0.00148	CcSEcCtD
Atazanavir—Weight decreased—Doxorubicin—bone cancer	0.000166	0.00148	CcSEcCtD
Atazanavir—Hyperglycaemia—Doxorubicin—bone cancer	0.000166	0.00148	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000162	0.00145	CcSEcCtD
Atazanavir—Hypersensitivity—Cisplatin—bone cancer	0.000162	0.00144	CcSEcCtD
Atazanavir—Renal failure—Doxorubicin—bone cancer	0.000161	0.00143	CcSEcCtD
Atazanavir—Erythema multiforme—Methotrexate—bone cancer	0.000161	0.00143	CcSEcCtD
Atazanavir—Neuropathy peripheral—Doxorubicin—bone cancer	0.000161	0.00143	CcSEcCtD
Atazanavir—Stomatitis—Doxorubicin—bone cancer	0.00016	0.00142	CcSEcCtD
Atazanavir—Jaundice—Doxorubicin—bone cancer	0.00016	0.00142	CcSEcCtD
Atazanavir—Urinary tract infection—Doxorubicin—bone cancer	0.000159	0.00142	CcSEcCtD
Atazanavir—Hepatitis—Epirubicin—bone cancer	0.000159	0.00142	CcSEcCtD
Atazanavir—Eye disorder—Methotrexate—bone cancer	0.000159	0.00141	CcSEcCtD
Atazanavir—Tinnitus—Methotrexate—bone cancer	0.000158	0.00141	CcSEcCtD
Atazanavir—Hypoaesthesia—Epirubicin—bone cancer	0.000158	0.00141	CcSEcCtD
Atazanavir—Asthenia—Cisplatin—bone cancer	0.000158	0.0014	CcSEcCtD
Atazanavir—Cardiac disorder—Methotrexate—bone cancer	0.000158	0.0014	CcSEcCtD
Atazanavir—Sweating—Doxorubicin—bone cancer	0.000157	0.0014	CcSEcCtD
Atazanavir—Urinary tract disorder—Epirubicin—bone cancer	0.000157	0.0014	CcSEcCtD
Atazanavir—Oedema peripheral—Epirubicin—bone cancer	0.000157	0.00139	CcSEcCtD
Atazanavir—Haematuria—Doxorubicin—bone cancer	0.000156	0.00139	CcSEcCtD
Atazanavir—Connective tissue disorder—Epirubicin—bone cancer	0.000156	0.00139	CcSEcCtD
Atazanavir—Urethral disorder—Epirubicin—bone cancer	0.000156	0.00139	CcSEcCtD
Atazanavir—Hepatobiliary disease—Doxorubicin—bone cancer	0.000155	0.00138	CcSEcCtD
Atazanavir—Angiopathy—Methotrexate—bone cancer	0.000154	0.00137	CcSEcCtD
Atazanavir—Immune system disorder—Methotrexate—bone cancer	0.000153	0.00137	CcSEcCtD
Atazanavir—Mediastinal disorder—Methotrexate—bone cancer	0.000153	0.00136	CcSEcCtD
Atazanavir—Diarrhoea—Cisplatin—bone cancer	0.00015	0.00134	CcSEcCtD
Atazanavir—Erythema multiforme—Epirubicin—bone cancer	0.00015	0.00134	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—bone cancer	0.00015	0.00134	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—bone cancer	0.000149	0.00132	CcSEcCtD
Atazanavir—Eye disorder—Epirubicin—bone cancer	0.000149	0.00132	CcSEcCtD
Atazanavir—Tinnitus—Epirubicin—bone cancer	0.000148	0.00132	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—bone cancer	0.000148	0.00132	CcSEcCtD
Atazanavir—Cardiac disorder—Epirubicin—bone cancer	0.000147	0.00131	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—bone cancer	0.000147	0.00131	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—bone cancer	0.000146	0.0013	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—bone cancer	0.000145	0.00129	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—bone cancer	0.000145	0.00129	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—bone cancer	0.000145	0.00129	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—bone cancer	0.000144	0.00129	CcSEcCtD
Atazanavir—Angiopathy—Epirubicin—bone cancer	0.000144	0.00128	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—bone cancer	0.000144	0.00128	CcSEcCtD
Atazanavir—Immune system disorder—Epirubicin—bone cancer	0.000144	0.00128	CcSEcCtD
Atazanavir—Mediastinal disorder—Epirubicin—bone cancer	0.000143	0.00128	CcSEcCtD
Atazanavir—Back pain—Methotrexate—bone cancer	0.000143	0.00127	CcSEcCtD
Atazanavir—Alopecia—Epirubicin—bone cancer	0.00014	0.00125	CcSEcCtD
Atazanavir—Vomiting—Cisplatin—bone cancer	0.00014	0.00124	CcSEcCtD
Atazanavir—Mental disorder—Epirubicin—bone cancer	0.000139	0.00124	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—bone cancer	0.000139	0.00124	CcSEcCtD
Atazanavir—Rash—Cisplatin—bone cancer	0.000139	0.00123	CcSEcCtD
Atazanavir—Dermatitis—Cisplatin—bone cancer	0.000138	0.00123	CcSEcCtD
Atazanavir—Malnutrition—Epirubicin—bone cancer	0.000138	0.00123	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—bone cancer	0.000137	0.00122	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—bone cancer	0.000137	0.00122	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—bone cancer	0.000137	0.00122	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—bone cancer	0.000136	0.00122	CcSEcCtD
Atazanavir—Flatulence—Epirubicin—bone cancer	0.000136	0.00121	CcSEcCtD
Atazanavir—Tension—Epirubicin—bone cancer	0.000136	0.00121	CcSEcCtD
Atazanavir—Dysgeusia—Epirubicin—bone cancer	0.000135	0.00121	CcSEcCtD
Atazanavir—Nervousness—Epirubicin—bone cancer	0.000134	0.0012	CcSEcCtD
Atazanavir—Back pain—Epirubicin—bone cancer	0.000134	0.00119	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—bone cancer	0.000133	0.00119	CcSEcCtD
Atazanavir—Malaise—Methotrexate—bone cancer	0.000133	0.00119	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—bone cancer	0.000133	0.00118	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—bone cancer	0.000133	0.00118	CcSEcCtD
Atazanavir—Nausea—Cisplatin—bone cancer	0.000131	0.00116	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—bone cancer	0.00013	0.00116	CcSEcCtD
Atazanavir—Cough—Methotrexate—bone cancer	0.000129	0.00115	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—bone cancer	0.000129	0.00115	CcSEcCtD
Atazanavir—Ill-defined disorder—Epirubicin—bone cancer	0.000128	0.00114	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—bone cancer	0.000128	0.00114	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—bone cancer	0.000128	0.00114	CcSEcCtD
Atazanavir—Agitation—Epirubicin—bone cancer	0.000127	0.00113	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—bone cancer	0.000126	0.00112	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—bone cancer	0.000126	0.00112	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—bone cancer	0.000126	0.00112	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—bone cancer	0.000126	0.00112	CcSEcCtD
Atazanavir—Tension—Doxorubicin—bone cancer	0.000126	0.00112	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—bone cancer	0.000125	0.00112	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000125	0.00111	CcSEcCtD
Atazanavir—Malaise—Epirubicin—bone cancer	0.000125	0.00111	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—bone cancer	0.000124	0.00111	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—bone cancer	0.000124	0.00111	CcSEcCtD
Atazanavir—Syncope—Epirubicin—bone cancer	0.000124	0.0011	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—bone cancer	0.000124	0.0011	CcSEcCtD
Atazanavir—Palpitations—Epirubicin—bone cancer	0.000122	0.00109	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—bone cancer	0.000122	0.00108	CcSEcCtD
Atazanavir—Loss of consciousness—Epirubicin—bone cancer	0.000122	0.00108	CcSEcCtD
Atazanavir—Cough—Epirubicin—bone cancer	0.000121	0.00108	CcSEcCtD
Atazanavir—Convulsion—Epirubicin—bone cancer	0.00012	0.00107	CcSEcCtD
Atazanavir—Infection—Methotrexate—bone cancer	0.00012	0.00107	CcSEcCtD
Atazanavir—Hypertension—Epirubicin—bone cancer	0.000119	0.00106	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—bone cancer	0.000119	0.00106	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—bone cancer	0.000118	0.00105	CcSEcCtD
Atazanavir—Chest pain—Epirubicin—bone cancer	0.000118	0.00105	CcSEcCtD
Atazanavir—Arthralgia—Epirubicin—bone cancer	0.000118	0.00105	CcSEcCtD
Atazanavir—Myalgia—Epirubicin—bone cancer	0.000118	0.00105	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—bone cancer	0.000118	0.00105	CcSEcCtD
Atazanavir—Anxiety—Epirubicin—bone cancer	0.000117	0.00105	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—bone cancer	0.000117	0.00104	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000117	0.00104	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—bone cancer	0.000117	0.00104	CcSEcCtD
Atazanavir—Discomfort—Epirubicin—bone cancer	0.000116	0.00104	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—bone cancer	0.000115	0.00103	CcSEcCtD
Atazanavir—Dry mouth—Epirubicin—bone cancer	0.000115	0.00103	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—bone cancer	0.000115	0.00102	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—bone cancer	0.000115	0.00102	CcSEcCtD
Atazanavir—Confusional state—Epirubicin—bone cancer	0.000114	0.00101	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—bone cancer	0.000113	0.00101	CcSEcCtD
Atazanavir—Oedema—Epirubicin—bone cancer	0.000113	0.00101	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—bone cancer	0.000113	0.001	CcSEcCtD
Atazanavir—Infection—Epirubicin—bone cancer	0.000112	0.000999	CcSEcCtD
Atazanavir—Cough—Doxorubicin—bone cancer	0.000112	0.000995	CcSEcCtD
Atazanavir—Shock—Epirubicin—bone cancer	0.000111	0.000989	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—bone cancer	0.000111	0.000988	CcSEcCtD
Atazanavir—Nervous system disorder—Epirubicin—bone cancer	0.000111	0.000986	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—bone cancer	0.000111	0.000984	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00011	0.000979	CcSEcCtD
Atazanavir—Skin disorder—Epirubicin—bone cancer	0.00011	0.000977	CcSEcCtD
Atazanavir—Hyperhidrosis—Epirubicin—bone cancer	0.000109	0.000972	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—bone cancer	0.000109	0.000972	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—bone cancer	0.000109	0.000971	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—bone cancer	0.000109	0.000971	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—bone cancer	0.000109	0.000971	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—bone cancer	0.000109	0.000967	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000108	0.000964	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—bone cancer	0.000108	0.000959	CcSEcCtD
Atazanavir—Anorexia—Epirubicin—bone cancer	0.000108	0.000958	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—bone cancer	0.000108	0.000958	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—bone cancer	0.000107	0.000955	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—bone cancer	0.000107	0.000949	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—bone cancer	0.000106	0.000946	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—bone cancer	0.000105	0.000938	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—bone cancer	0.000105	0.000934	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—bone cancer	0.000104	0.00093	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—bone cancer	0.000104	0.000928	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—bone cancer	0.000104	0.000926	CcSEcCtD
Atazanavir—Infection—Doxorubicin—bone cancer	0.000104	0.000924	CcSEcCtD
Atazanavir—Pain—Methotrexate—bone cancer	0.000103	0.000919	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000103	0.000916	CcSEcCtD
Atazanavir—Shock—Doxorubicin—bone cancer	0.000103	0.000915	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—bone cancer	0.000102	0.000912	CcSEcCtD
Atazanavir—Insomnia—Epirubicin—bone cancer	0.000102	0.000909	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—bone cancer	0.000101	0.000904	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—bone cancer	0.000101	0.000899	CcSEcCtD
Atazanavir—Dyspnoea—Epirubicin—bone cancer	0.000101	0.000896	CcSEcCtD
Atazanavir—Somnolence—Epirubicin—bone cancer	0.0001	0.000894	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—bone cancer	9.96e-05	0.000887	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—bone cancer	9.94e-05	0.000885	CcSEcCtD
Atazanavir—Dyspepsia—Epirubicin—bone cancer	9.94e-05	0.000885	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—bone cancer	9.87e-05	0.000879	CcSEcCtD
Atazanavir—Decreased appetite—Epirubicin—bone cancer	9.81e-05	0.000874	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Epirubicin—bone cancer	9.75e-05	0.000868	CcSEcCtD
Atazanavir—Fatigue—Epirubicin—bone cancer	9.73e-05	0.000867	CcSEcCtD
Atazanavir—Pain—Epirubicin—bone cancer	9.65e-05	0.00086	CcSEcCtD
Atazanavir—Constipation—Epirubicin—bone cancer	9.65e-05	0.00086	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—bone cancer	9.58e-05	0.000854	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—bone cancer	9.54e-05	0.000849	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—bone cancer	9.54e-05	0.000849	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.52e-05	0.000848	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—bone cancer	9.45e-05	0.000841	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—bone cancer	9.31e-05	0.000829	CcSEcCtD
Atazanavir—Feeling abnormal—Epirubicin—bone cancer	9.3e-05	0.000829	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—bone cancer	9.29e-05	0.000827	CcSEcCtD
Atazanavir—Gastrointestinal pain—Epirubicin—bone cancer	9.23e-05	0.000822	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—bone cancer	9.2e-05	0.000819	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—bone cancer	9.08e-05	0.000809	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—bone cancer	9.02e-05	0.000803	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—bone cancer	9.01e-05	0.000802	CcSEcCtD
Atazanavir—Urticaria—Epirubicin—bone cancer	8.97e-05	0.000799	CcSEcCtD
Atazanavir—Pain—Doxorubicin—bone cancer	8.93e-05	0.000796	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—bone cancer	8.93e-05	0.000796	CcSEcCtD
Atazanavir—Abdominal pain—Epirubicin—bone cancer	8.93e-05	0.000795	CcSEcCtD
Atazanavir—Body temperature increased—Epirubicin—bone cancer	8.93e-05	0.000795	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—bone cancer	8.89e-05	0.000792	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—bone cancer	8.66e-05	0.000771	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—bone cancer	8.61e-05	0.000767	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—bone cancer	8.54e-05	0.000761	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—bone cancer	8.54e-05	0.00076	CcSEcCtD
Atazanavir—Hypersensitivity—Epirubicin—bone cancer	8.32e-05	0.000741	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—bone cancer	8.3e-05	0.000739	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—bone cancer	8.26e-05	0.000735	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—bone cancer	8.26e-05	0.000735	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—bone cancer	8.25e-05	0.000735	CcSEcCtD
Atazanavir—Asthenia—Epirubicin—bone cancer	8.1e-05	0.000721	CcSEcCtD
Atazanavir—Pruritus—Epirubicin—bone cancer	7.99e-05	0.000711	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—bone cancer	7.98e-05	0.000711	CcSEcCtD
Atazanavir—Diarrhoea—Epirubicin—bone cancer	7.73e-05	0.000688	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—bone cancer	7.7e-05	0.000685	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—bone cancer	7.67e-05	0.000683	CcSEcCtD
Atazanavir—Rash—Methotrexate—bone cancer	7.61e-05	0.000677	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—bone cancer	7.6e-05	0.000677	CcSEcCtD
Atazanavir—Headache—Methotrexate—bone cancer	7.56e-05	0.000673	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—bone cancer	7.5e-05	0.000668	CcSEcCtD
Atazanavir—Dizziness—Epirubicin—bone cancer	7.47e-05	0.000665	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—bone cancer	7.39e-05	0.000658	CcSEcCtD
Atazanavir—Vomiting—Epirubicin—bone cancer	7.18e-05	0.000639	CcSEcCtD
Atazanavir—Nausea—Methotrexate—bone cancer	7.17e-05	0.000638	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—bone cancer	7.15e-05	0.000637	CcSEcCtD
Atazanavir—Rash—Epirubicin—bone cancer	7.12e-05	0.000634	CcSEcCtD
Atazanavir—Dermatitis—Epirubicin—bone cancer	7.11e-05	0.000633	CcSEcCtD
Atazanavir—Headache—Epirubicin—bone cancer	7.07e-05	0.00063	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—bone cancer	6.91e-05	0.000615	CcSEcCtD
Atazanavir—Nausea—Epirubicin—bone cancer	6.71e-05	0.000597	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—bone cancer	6.64e-05	0.000592	CcSEcCtD
Atazanavir—Rash—Doxorubicin—bone cancer	6.59e-05	0.000587	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—bone cancer	6.58e-05	0.000586	CcSEcCtD
Atazanavir—Headache—Doxorubicin—bone cancer	6.54e-05	0.000583	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—bone cancer	6.21e-05	0.000553	CcSEcCtD
